Hanseatic Management Services’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.06M Buy
3,183
+63
+2% +$21.8K 0.87% 45
2026
Q2
$1.16M Buy
3,120
+123
+4% +$36.8K 0.85% 49
2026
Q1
$774K Buy
+2,997
New +$797K 0.74% 51

Other funds holding KRYS

Hanseatic Management Services's KRYS Position: Q3 2026 in Review

Hanseatic Management Services increased its Krystal Biotech (KRYS) stake by 2% in Q3 2026, buying an estimated $21.8K and bringing the position to 3,183 shares worth $1.06M. The position accounts for 0.87% of the portfolio, ranked #45.

Hanseatic Management Services first reported a position in KRYS in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.16M in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Hanseatic Management Services held 3,183 shares of Krystal Biotech worth $1.06M as of Q3 2026.
  • Hanseatic Management Services bought 63 Krystal Biotech shares in Q3 2026, an estimated $21.8K.
  • Krystal Biotech made up 0.87% of Hanseatic Management Services's portfolio in Q3 2026, its #45 holding.
  • Hanseatic Management Services first reported a position in Krystal Biotech in Q1 2026 and has held it in 3 quarters since.
  • Hanseatic Management Services's Krystal Biotech position peaked at $1.16M in Q2 2026.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Hanseatic Management Services's 13F filing for Q3 2026, filed 22 Oct 2026.